GB0704394D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB0704394D0
GB0704394D0 GB0704394A GB0704394A GB0704394D0 GB 0704394 D0 GB0704394 D0 GB 0704394D0 GB 0704394 A GB0704394 A GB 0704394A GB 0704394 A GB0704394 A GB 0704394A GB 0704394 D0 GB0704394 D0 GB 0704394D0
Authority
GB
Grant status
Grant
Patent type
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0704394A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Senexis Ltd
Original Assignee
Senexis Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Grant date

Links

GB0704394A 2007-03-07 2007-03-07 Compounds Ceased GB0704394D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0704394A GB0704394D0 (en) 2007-03-07 2007-03-07 Compounds

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0704394A GB0704394D0 (en) 2007-03-07 2007-03-07 Compounds
PCT/GB2008/000761 WO2008107677A3 (en) 2007-03-07 2008-03-06 Thiadiazole and oxadiazole derivatives for the treatment of neurodegenerative disorders

Publications (1)

Publication Number Publication Date
GB0704394D0 true GB0704394D0 (en) 2007-04-11

Family

ID=37966087

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0704394A Ceased GB0704394D0 (en) 2007-03-07 2007-03-07 Compounds

Country Status (2)

Country Link
GB (1) GB0704394D0 (en)
WO (1) WO2008107677A3 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10303974A1 (en) 2003-01-31 2004-08-05 Abbott Gmbh & Co. Kg Amyloid-β (1-42) oligomers, processes for their preparation and their use
ES2527661T3 (en) 2005-11-30 2015-01-28 Abbvie Inc. Scan method, process for purifying oligomers Abeta not diffusible, selective antibodies against Abeta such oligomers not diffusible and a process for making such antibodies
US8455626B2 (en) 2006-11-30 2013-06-04 Abbott Laboratories Aβ conformer selective anti-aβ globulomer monoclonal antibodies
US8895004B2 (en) 2007-02-27 2014-11-25 AbbVie Deutschland GmbH & Co. KG Method for the treatment of amyloidoses
EP2177521A1 (en) * 2008-10-14 2010-04-21 Almirall, S.A. New 2-Amidothiadiazole Derivatives
EP2305660A1 (en) * 2009-09-25 2011-04-06 Almirall, S.A. New thiadiazole derivatives
EP2343287A1 (en) * 2009-12-10 2011-07-13 Almirall, S.A. New 2-aminothiadiazole derivatives
EP2558494B1 (en) 2010-04-15 2018-05-23 AbbVie Inc. Amyloid-beta binding proteins
US9200008B2 (en) * 2010-07-02 2015-12-01 Aska Pharmaceutical Co., Ltd. Heterocyclic compound and p27Kip1 degradation inhibitor
US9062101B2 (en) 2010-08-14 2015-06-23 AbbVie Deutschland GmbH & Co. KG Amyloid-beta binding proteins
US8729263B2 (en) 2012-08-13 2014-05-20 Novartis Ag 1,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditions
US9040712B2 (en) 2013-01-23 2015-05-26 Novartis Ag Thiadiazole analogs thereof and methods for treating SMN-deficiency-related-conditions
WO2016153023A1 (en) * 2015-03-25 2016-09-29 国立研究開発法人国立長寿医療研究センター Novel oxadiazole derivative and pharmaceutical containing same
CN105384736A (en) * 2015-10-28 2016-03-09 南昌大学 IV type collagenase inhibitor and synthesis method thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005020991A1 (en) * 2003-08-21 2005-03-10 Pfizer Products, Inc. Compounds for the treatment of neurodegenerative disorders
WO2005072731A1 (en) * 2004-01-29 2005-08-11 X-Ceptor Therapeutics, Inc. 3-phenyl-n- ((1, 3, 4) thiadiazol-2-yl) -acrylamide derivatives and related compounds as modulators of estrogen-related receptors for the treatment of e.g. cancer, rheumatoid arthritis or neurological disorders
US7232820B2 (en) * 2004-04-01 2007-06-19 Pfizer Inc Thiadiazole-amine compounds for the treatment of neurodegenerative disorders
GB0608386D0 (en) * 2006-04-27 2006-06-07 Senexis Ltd Compounds

Also Published As

Publication number Publication date Type
WO2008107677A3 (en) 2008-10-30 application
WO2008107677A2 (en) 2008-09-12 application

Similar Documents

Publication Publication Date Title
GB0707107D0 (en) Know-where
GB0705774D0 (en) Crushabin
DE602008004757D1 (en) Oximesther-fotoinitiatoren
GB0715364D0 (en) Hitchlock
GB0714676D0 (en) Note015
DE602008003418D1 (en) Fluxgate-sensor
GB0707996D0 (en) Eco-link
GB0713325D0 (en) Tri-pool
GB0718340D0 (en) Adultfunboard
GB0711969D0 (en) Stic-up
GB0711787D0 (en) Greenmobil
GB0716272D0 (en) Anti-flood-gate
GB0705849D0 (en) Jellyloss
GB0717745D0 (en) Brucee
GB0705957D0 (en) Meltometer
GB0709702D0 (en) Powersave
GB0710823D0 (en) Wheelshield
GB0700800D0 (en) Kitti-mat
GB0706960D0 (en) Frutree
GB0716949D0 (en) Plugsafe
GB0707225D0 (en) Snifsafe
GB0716271D0 (en) SafekeyP
GB0706044D0 (en) C0-Crystals
GB0704292D0 (en) Satwalk
GB0709205D0 (en) Johnstern

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)